Literature DB >> 16003840

Genomic rearrangements in MSH2 and MLH1 are rare mutational events in Spanish patients with hereditary nonpolyposis colorectal cancer.

Sergi Castellví-Bel1, Antoni Castells, Mark Strunk, Angel Ferrández, Elena Piazuelo, Montserrat Milà, Virgínia Piñol, Francisco Rodríguez-Moranta, Montserrat Andreu, Angel Lanas, Josep Maria Piqué.   

Abstract

Colorectal cancer (CRC) is one of the most common neoplasms and a leading cause of death related to cancer worldwide. Hereditary nonpolyposis colorectal cancer (HNPCC) is the most frequent autosomal dominant predisposition to the development of CRC, accounting for approximately 2.5% of the total CRC burden in Spain. Genomic rearrangements in the MSH2 and MLH1 genes have been reported to account for an important proportion of the mutation spectrum in HNPCC, and DNA dosage techniques have been developed facilitating molecular screening of such deletions/duplications. We screened for MSH2 and MLH1 genomic rearrangements by multiplex ligation-dependent probe amplification (MLPA) in 142 Spanish patients at risk for HNPCC prior to the exon-by-exon mutation scanning and found a deletion encompassing exons 9-16 of MSH2 and a duplication encompassing exons 11-16 of MSH2, both only in one case. These results showed that MSH2/MLH1 rearrangements in Spanish patients at risk for HNPCC seem to be a less frequent mutational event than in other populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16003840     DOI: 10.1016/j.canlet.2005.01.036

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

1.  Partial duplication of MSH2 spanning exons 7 through 14 in Lynch syndrome.

Authors:  Mikio Shiozawa; Yasuyuki Miyakura; Makiko Tahara; Kazue Morishima; Hidetoshi Kumano; Koji Koinuma; Hisanaga Horie; Alan T Lefor; Naohiro Sata; Yoshikazu Yasuda; Kenji Gonda; Seiichi Takenoshita; Akihiko Tamura; Noriyoshi Fukushima; Kokichi Sugano
Journal:  J Gastroenterol       Date:  2013-04-18       Impact factor: 7.527

2.  Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.

Authors:  Gasper Berginc; Matej Bracko; Metka Ravnik-Glavac; Damjan Glavac
Journal:  Fam Cancer       Date:  2009-06-13       Impact factor: 2.375

3.  Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.

Authors:  Katarina Zavodna; Tomas Krivulcik; Maria Gerykova Bujalkova; Tomas Slamka; David Martinicky; Denisa Ilencikova; Zdena Bartosova
Journal:  BMC Cancer       Date:  2009-11-20       Impact factor: 4.430

4.  Contribution of large genomic rearrangements in Italian Lynch syndrome patients: characterization of a novel alu-mediated deletion.

Authors:  Francesca Duraturo; Angela Cavallo; Raffaella Liccardo; Bianca Cudia; Marina De Rosa; Giuseppe Diana; Paola Izzo
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.